Replies to post #23369 on Mymetics Corp (MYMX)

[bow-tie]

May 27, 2020
Merck KGaA, Darmstadt, Germany and Baylor College
of Medicine Announce Collaboration to Advance a
Vaccine Manufacturing Platform to Fight Covid-19
• Company will focus on process development and improvements for
manufacturing Baylor’s Covid-19 vaccine candidates
Darmstadt, Germany, May 27, 2020 – Merck KGaA, Darmstadt, Germany, a leading
science and technology company, and Baylor College of Medicine today announced
today announced an extension of an on ongoing collaboration between Baylor and
the Life Science business of Merck KGaA, Darmstadt, Germany to advance a
manufacturing platform to fight Covid-19, designed to accelerate transition to Phase
1 clinical trials.

https://www.emdgroup.com/press-releases/2020/may/us/Baylor-vaccine-manufacturing-platform-Covid-19-NA.pdf

[Work Harder]

Sponsors and Collaborators Baylor College of Medicine

Bill and Melinda Gates Foundation

Investigators
Principal Investigator: Gary Simon, M.D., Ph.D George Washington University

Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection

https://www.clinicaltrials.gov/ct2/show/NCT00120081